Cancer driver topologically associated domains identify oncogenic and tumor-suppressive lncRNAs
Genome Research · 2025
DOI: 10.1101/gr.280235.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, 2025. Verfasst von Ziyan Rao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, School of Basic Medical Sciences, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplasms, Oncogenes, Genes, Tumor Suppressor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, NSFC.
Abstract (Originalsprache)
Cancer long noncoding RNAs (lncRNAs) have been identified by experimental and in silico methods. However, current approaches for identifying cancer lncRNAs are not sufficient and effective. To uncover them, we focus on the core cancer driver lncRNAs, which directly interact with cancer driver protein-coding genes (PCGs). We investigate various aspects of cancer lncRNAs, including their expression patterns, genomic locations, and direct interactions with cancer driver PCGs, and developed a pipeline to identify candidate cancer driver lncRNAs. Finally, we validate the reliability of potential cancer driver lncRNAs through functional analysis of bioinformatics data and CRISPR-Cas9 knockout experiments. We find that cancer lncRNAs are more concentrated in cancer driver topologically associated domains (CDTs), and CDT is an important feature in identifying cancer lncRNAs. Moreover, cancer lncRNAs show a high tendency to be coexpressed with and bind to cancer driver PCGs. Utilizing these distinctive characteristics, we develop a pipeline CA ncer D river T opologically A ssociated D omains (CADTAD) to identify candidate cancer driver lncRNAs in pan-cancer, including 256 oncogenic lncRNAs, 177 tumor-suppressive lncRNAs, and 75 dual-function lncRNAs, as well as in three individual cancer types, and validate their cancer-related functions. More importantly, the function of 10 putative cancer driver lncRNAs in prostate cancer is subsequently validated to influence cancer phenotype through cell studies. In light of these findings, our study offers a new perspective from the 3D genome to study the roles of lncRNAs in cancer. Furthermore, we provide a valuable set of potential lncRNAs that could deepen our understanding of the oncogenic mechanism of cancer driver lncRNAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Informatics, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China; zhaodongyu@bjmu.edu.cn minzh@zju.edu.cn.
- Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang 310058, China.
- Department of Orthopaedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
ORCID-Profile: Ziyan Rao
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- NSFC
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Rao, Z., Zhang, M., Huang, S., Wu, C., Zhou, Y., Zhang, W., Lin, X., & Zhao, D. (2025). Cancer driver topologically associated domains identify oncogenic and tumor-suppressive lncRNAs. Genome Research. https://doi.org/10.1101/gr.280235.124
Vancouver
Rao Z, Zhang M, Huang S, Wu C, Zhou Y, Zhang W, et al. Cancer driver topologically associated domains identify oncogenic and tumor-suppressive lncRNAs. Genome Research. 2025. doi:10.1101/gr.280235.124
BibTeX
@article{Rao2025,
author = {Rao, Ziyan and Zhang, Min and Huang, Shaodong and Wu, Chenyang and Zhou, Yuheng and Zhang, Weijie and Lin, Xia and Zhao, Dongyu},
title = {Cancer driver topologically associated domains identify oncogenic and tumor-suppressive lncRNAs},
journal = {Genome Research},
year = {2025},
doi = {10.1101/gr.280235.124}
}
EUVIMED